In addition to antidiabetic medications, some may also be prescribed by medical professionals for the treatment and management of obesity
When it comes to GLP-1 pills, only one is currently approved in the U.S
However, patients can be reassured that limited human data have not demonstrated consistent teratogenic patterns to date
Until robust phase III clinical trial data becomes available comparing transdermal and injectable GLP-1 formulations directly, healthcare professionals must rely on established injectable therapies with proven efficacy and safety profiles for managing type 2 diabetes and obesity
Many people see improvements in blood pressure, cholesterol levels, inflammation markers, and cardiovascular risk factors
A well-run telehealth practice can provide thoughtful, appropriate medical care